By: Alex Knapp
Startup Ataraxis, which emerged from stealth Thursday, has developed a model that can predict the risk severity of breast cancer up to 30% more accurately than current tests.
Alex Knapp is a senior editor at Forbes, specializing in healthcare, science, and cutting-edge technology. With a keen focus on topics ranging from the coronavirus to AI and markets, he has authored numerous profiles of entrepreneurs and conducted in-depth analyses of technological trends, including superconductors and space travel. Alex's work has been featured in KXLY-TV (Spokane, WA), Forbes Australia, Forbes, and Forbes Middle East.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Alex Knapp's coverage encompasses a variety of topics including healthcare, pharmaceuticals, sustainability, and innovation. He frequently focuses on groundbreaking startups, funding rounds, and innovative technologies within these fields.
Given the prevalence of press releases and data citations in his articles, it seems that Alex would be interested in receiving pitches related to new product launches or research findings supported by robust data. Additionally, he might also be open to stories about companies making significant contributions to healthcare or sustainability sectors.
As for government announcements being part of his coverage attributes at 11%, this suggests potential responsiveness to news regarding policy changes impacting the covered industries. Whether it’s advancements in biotech research or innovations within the space economy sector; they are all likely areas where Alex may respond well to well-pitched stories.
This information evolves through artificial intelligence and human feedback. Improve this profile .